Vaccitech plc - ADR
NASDAQ:VACC 3:59:56 PM EDT
Market Cap (Intraday) | 94.36M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $2.44 |
50-Day MA | $2.38 |
200-Day MA | $2.77 |
Vaccitech plc - ADR Stock, NASDAQ:VACC
Zeus Building, Rutherford Avenue, Didcot, Oxfordshire OX11 0DF
United Kingdom
Phone: +44.18.6581.8808
Number of Employees: 107
Description
Vaccitech Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.